Adalimumab treatment in Crohn's disease: an overview of long-term efficacy and safety in light of the EXTEND trial
about
Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn's Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study.Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countriesSafety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis.The rescue effect of adalimumab in the treatment of refractory pediatric panuveitis complicated with steroid-induced glaucoma
P2860
Adalimumab treatment in Crohn's disease: an overview of long-term efficacy and safety in light of the EXTEND trial
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Adalimumab treatment in Crohn' ...... y in light of the EXTEND trial
@ast
Adalimumab treatment in Crohn' ...... y in light of the EXTEND trial
@en
Adalimumab treatment in Crohn' ...... y in light of the EXTEND trial
@nl
type
label
Adalimumab treatment in Crohn' ...... y in light of the EXTEND trial
@ast
Adalimumab treatment in Crohn' ...... y in light of the EXTEND trial
@en
Adalimumab treatment in Crohn' ...... y in light of the EXTEND trial
@nl
prefLabel
Adalimumab treatment in Crohn' ...... y in light of the EXTEND trial
@ast
Adalimumab treatment in Crohn' ...... y in light of the EXTEND trial
@en
Adalimumab treatment in Crohn' ...... y in light of the EXTEND trial
@nl
P2093
P2860
P3181
P356
P1476
Adalimumab treatment in Crohn' ...... y in light of the EXTEND trial
@en
P2093
Amon Asgharpour
Jianfeng Cheng
Stephen Bickston
P2860
P304
P3181
P356
10.2147/CEG.S35163
P407
P577
2013-08-30T00:00:00Z